AlphaFold 3 models all the molecular interactions of living organisms
Google DeepMind released AlphaFold 3 in May 2024, a model capable of predicting the structure and interactions of all biological molecules: proteins, DNA, RNA, ligands and small molecules. Accuracy reaches 76% on protein-ligand complexes, a 50% leap compared to previous methods. The pharmaceutical sector sees it as a major accelerator of drug discovery.
Opportunities for businesses
AlphaFold 3's ability to model molecular interactions creates concrete opportunities well beyond fundamental research. Three sectors are particularly concerned.
Pharma & drug discovery
Identify drug candidates in a few days instead of several months. Sanofi estimates a 40% gain on the cost of preclinical phases thanks to in silico modeling.
Biotech & diagnostics
Design custom antibodies and biosensors. Startups use AlphaFold 3 to accelerate the design of diagnostic tools by 3 to 5 times.
Food & agriculture
Improve industrial enzymes for food fermentation and preservation. BASF announced a 25% reduction in enzyme optimization cycles.
Risks to anticipate
Technological dependence
AlphaFold 3 is controlled by Google via Isomorphic Labs. The predictions are reliable but opaque: it is impossible to fully audit the model. Companies must plan for a systematic experimental validation strategy.
Intellectual property
AI-generated structures raise questions of patentability. The EPO (European Patent Office) has not yet ruled clearly on the protection of molecules designed by AI. Consult an IP advisor before filing a patent based on these predictions.
Our recommendations
Assess your internal use cases
Identify the R&D projects where molecular modeling represents a bottleneck. Prioritize cases where the time savings exceed 3 months.
Launch a POC on an existing pipeline
Integrate AlphaFold 3 into an ongoing project to compare the results with your current methods. Indicative budget: 15,000 to 30,000 EUR for a 6-week POC.
Train your teams and secure your IP
Organize training for your researchers on using the AlphaFold server. In parallel, have your patent filing processes audited by a firm specialized in AI-IP.
Key takeaways
Frequently asked questions
Is AlphaFold 3 accessible to life sciences SMBs?
Yes. Google offers free access via the AlphaFold server for academic research. For commercial use, a license via Isomorphic Labs is required, but the costs remain lower than those of a conventional screening campaign.
What is the difference between AlphaFold 2 and AlphaFold 3?
AlphaFold 2 predicted only the 3D structure of proteins. AlphaFold 3 also models the interactions between proteins, DNA, RNA, ligands and small molecules, which paves the way for AI-assisted drug design.
Do you need bioinformatics skills to use AlphaFold 3?
The web interface is accessible to researchers without technical expertise. However, integrating it into a drug discovery pipeline requires bioinformatics skills or the support of a specialized partner.
AlphaFold 3 tech sheet
AlphaFold 3
Molecular structure prediction model based on a diffusion architecture. Trained on the PDB and enriched with proprietary data.
Pricing
Comparison
| Criterion | AlphaFold 3 | RoseTTAFold All-Atom | ESMFold |
|---|---|---|---|
| Multi-molecule interactions | Yes | Partial | No |
| Accuracy (LDDT) | 0.89 | 0.82 | 0.73 |
| Free cloud access | Yes | Yes | Yes |
| On-premise deployment | Restricted | Yes | Yes |